Suppr超能文献

口服抗凝治疗与死亡风险:一项医疗记录关联研究。

Oral anticoagulation and risk of death: a medical record linkage study.

作者信息

Odén Anders, Fahlén Martin

机构信息

Valler 190, S-442 92 Romelanda, Sweden.

出版信息

BMJ. 2002 Nov 9;325(7372):1073-5. doi: 10.1136/bmj.325.7372.1073.

Abstract

OBJECTIVE

To study how mortality varies with different degrees of anticoagulation reflected by the international normalised ratio (INR).

DESIGN

Record linkage analysis with death hazard estimated as a continuous function of INR.

DATA SOURCES

46 anticoagulation clinics in Sweden with computerised medical records.

SUBJECTS

Records for 42 451 patients, 3533 deaths, and 1.25 million INR measurements.

MAIN OUTCOME MEASURES

Mortality from all causes and from intracranial haemorrhage.

RESULTS

Mortality from all causes of death was strongly related to level of INR. Minimum risk of death was attained at 2.2 INR for all patients and 2.3 INR for patients with mechanical heart valve prostheses. A high INR was associated with an excess mortality: with an increase of 1 unit of INR above 2.5, the risks of death from cerebral bleeding (149 deaths) and from any cause were about doubled. Among patients with an INR of > or =3.0, 1069 deaths occurred within 7 weeks; if the risk coincided with that with an INR of 2.9, the expected number of deaths would have been 569. Thus at least 500 deaths were associated with a high INR value, but not necessarily caused by the treatment.

CONCLUSIONS

The excess mortality associated with high INR values supports the use of less intensive treatment and a small therapeutic window, with INR close to 2.2-2.3 irrespective of the indication for anticoagulant treatment. More preventive actions should be taken to avoid episodes of high INR.

摘要

目的

研究死亡率如何随国际标准化比值(INR)所反映的不同抗凝程度而变化。

设计

进行记录链接分析,将死亡风险估计为INR的连续函数。

数据来源

瑞典46家抗凝诊所的计算机化病历。

研究对象

42451例患者的记录、3533例死亡病例以及125万次INR测量值。

主要观察指标

全因死亡率和颅内出血死亡率。

结果

全因死亡率与INR水平密切相关。所有患者的INR为2.2时死亡风险最低,机械心脏瓣膜置换患者的INR为2.3时死亡风险最低。INR升高与死亡率增加相关:INR高于2.5每增加1个单位,脑出血(149例死亡)和全因死亡风险约增加一倍。在INR≥3.0的患者中,7周内发生了1069例死亡;如果风险与INR为2.9时一致,预期死亡人数应为569例。因此,至少500例死亡与高INR值相关,但不一定由治疗引起。

结论

与高INR值相关的额外死亡率支持采用强度较低的治疗方法和较窄的治疗窗,无论抗凝治疗指征如何,INR接近2.2 - 2.3。应采取更多预防措施以避免出现高INR情况。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验